Price Alert

BioNTech SE (BNTX)

NASDAQ: BNTX · Real-Time Price · USD

105.49

0.98 (0.94%)

At close: Oct 03, 2025, 3:59 PM

105.48

-0.01%

After-hours: Oct 03, 2025, 06:50 PM EDT

BioNTech SE Statistics

Share Statistics

BioNTech SE has 240.4M shares outstanding. The number of shares has increased by 0.27% in one year.

Shares Outstanding	240.4M
Shares Change (YoY)	0.27%
Shares Change (QoQ)	0%
Owned by Institutions (%)	22.05%
Shares Floating	236.73M
Failed to Deliver (FTD) Shares	9
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 6.38M, so 2.65% of the outstanding shares have been sold short.

Short Interest	6.38M
Short % of Shares Out	2.65%
Short % of Float	6.91%
Short Ratio (days to cover)	4.19

Valuation Ratios

The PE ratio is -39.76 and the forward PE ratio is -25.06. BioNTech SE's PEG ratio is 0.23.

PE Ratio	-39.76
Forward PE	-25.06
PS Ratio	9.62
Forward PS	8.5
PB Ratio	1.36
P/FCF Ratio	-108.15
PEG Ratio	0.23

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for BioNTech SE.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.45, with a Debt / Equity ratio of 0.01.

Current Ratio	7.45
Quick Ratio	7.34
Debt / Equity	0.01
Debt / EBITDA	-0.69
Debt / FCF	-1.04
Interest Coverage	-104.31

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$406.25K
Profits Per Employee	$-98.24K
Employee Count	6,772
Asset Turnover	0.12
Inventory Turnover	1.91

Taxes

Income Tax	-12.4M
Effective Tax Rate	1.83%

Stock Price Statistics

The stock price has increased by -14.01% in the last 52 weeks. The beta is 1.46, so BioNTech SE's price volatility has been higher than the market average.

Beta	1.46
52-Week Price Change	-14.01%
50-Day Moving Average	105.29
200-Day Moving Average	106.92
Relative Strength Index (RSI)	58.05
Average Volume (20 Days)	880,201

Income Statement

In the last 12 months, BioNTech SE had revenue of 2.75B and earned -665.3M in profits. Earnings per share was -2.77.

Revenue	2.75B
Gross Profit	2.21B
Operating Income	-1.31B
Net Income	-665.3M
EBITDA	-367.1M
EBIT	-665.1M
Earnings Per Share (EPS)	-2.77

Full Income Statement

Balance Sheet

The company has 9.76B in cash and 254.2M in debt, giving a net cash position of 9.51B.

Cash & Cash Equivalents	9.76B
Total Debt	254.2M
Net Cash	9.51B
Retained Earnings	19.1B
Total Assets	21.64B
Working Capital	14.08B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 207.7M and capital expenditures -452.3M, giving a free cash flow of -244.6M.

Operating Cash Flow	207.7M
Capital Expenditures	-452.3M
Free Cash Flow	-244.6M
FCF Per Share	-1.02

Full Cash Flow Statement

Margins

Gross margin is 80.32%, with operating and profit margins of -47.77% and -24.18%.

Gross Margin	80.32%
Operating Margin	-47.77%
Pretax Margin	-24.63%
Profit Margin	-24.18%
EBITDA Margin	-13.34%
EBIT Margin	-47.77%
FCF Margin	-8.89%

Dividends & Yields

BNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for BNTX is $135, which is 28% higher than the current price. The consensus rating is "Buy".

Price Target	$135
Price Target Difference	28%
Analyst Consensus	Buy
Analyst Count	13

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	6.54
Piotroski F-Score	4